EF Hutton analyst Chip Moore maintains Aspen Aerogels (NYSE:ASPN) with a Buy and lowers the price target from $48 to $18.
The Analyst Verdict: Gilead Sciences In The Eyes Of 12 Experts
In the last three months, 12 analysts have published ratings on Gilead Sciences (NASDAQ:GILD), offering a diverse range…